메뉴 건너뛰기




Volumn 16, Issue 6, 2002, Pages 375-377

Doxazosin, an inferior antihypertensive agent?

Author keywords

Doxazosin

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; LISINOPRIL;

EID: 0036085838     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001313     Document Type: Note
Times cited : (4)

References (9)
  • 1
    • 0031044480 scopus 로고    scopus 로고
    • Health outcomes associated with various antihypertensive therapies used as first-line agents. A systematic review and meta-analysis
    • (1997) JAMA , vol.277 , pp. 739-745
    • Psaty, B.M.1
  • 3
    • 0029918188 scopus 로고    scopus 로고
    • Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    • (1996) Am J Hypertens , vol.9 , pp. 342-360
    • Davis, B.R.1
  • 4
    • 0035156493 scopus 로고    scopus 로고
    • Baseline characteristics of participants in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    • (2001) Hypertension , vol.37 , pp. 19-27
    • Grimm R.H., Jr.1
  • 5
    • 0034685403 scopus 로고    scopus 로고
    • Major cardiovascular events in hypertensive patients randomized to doxazosin vs. chlorthalidone. The Antihypertensive and Lipid-Lowering Treatment to to Prevent Heart Attack Trial (ALLHAT)
    • (2000) JAMA , vol.283 , pp. 1967-1975
  • 7
  • 9
    • 0034688194 scopus 로고    scopus 로고
    • Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
    • (2000) N Engl J Med , vol.342 , pp. 145-153


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.